Growth Metrics

Cytosorbents (CTSO) Share-based Compensation Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 4.10%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 5.54%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 5.09%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 14.70%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 5.29%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 7.15%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 13.40%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 12.36%
10 Cytosorbents 28.81 Mn 24.01 Mn 6.13 Mn -13.14%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -13.14%
Dec 31, 2025 0.63%
Sep 30, 2025 -21.40%
Jun 30, 2025 -9.13%
Mar 31, 2025 1.28%
Dec 31, 2024 4.91%
Sep 30, 2024 -3.74%
Jun 30, 2024 -14.06%
Mar 31, 2024 -14.92%
Dec 31, 2023 -12.83%
Sep 30, 2023 -0.06%
Jun 30, 2023 -18.32%
Mar 31, 2023 4.40%
Dec 31, 2022 20.98%
Sep 30, 2022 7.81%
Jun 30, 2022 73.78%
Mar 31, 2022 51.23%
Dec 31, 2021 -20.30%
Sep 30, 2021 53.91%
Jun 30, 2021 -8.98%
Mar 31, 2021 92.85%
Dec 31, 2020 19.86%
Sep 30, 2020 4.26%
Jun 30, 2020 9.41%
Mar 31, 2020 99.20%
Dec 31, 2019 54.36%
Sep 30, 2019 86.19%
Jun 30, 2019 -33.48%
Mar 31, 2019 28.58%
Dec 31, 2018 134.48%
Sep 30, 2018 34.03%
Jun 30, 2018 192.16%
Mar 31, 2018 50.61%
Sep 30, 2017 133.67%
Jun 30, 2017 156.22%
Mar 31, 2017 17.17%
Dec 31, 2016 -40.06%
Sep 30, 2016 37.83%
Jun 30, 2016 129.82%
Mar 31, 2016 -22.03%
Dec 31, 2015 38.28%
Sep 30, 2015 109.19%
Jun 30, 2015 174.63%
Mar 31, 2015 392.57%
Sep 30, 2014 -38.91%
Jun 30, 2014 189.56%
Mar 31, 2014 -31.19%
Dec 31, 2013 112.61%
Sep 30, 2013 -129.43%